Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study).
Saifuddin M, Paul AK, Shefin SM, Alam MJ, Selim S, Islam S, Hossain T, Tuqan S, Sultana N, Mustari M, Basak RC, Aftab KA, Prasad I, Uddin MR, Sharker S, Gaffar MAJ, Rahman MM, Hannan MA, Ahammed A, Kamrul-Hasan A. Saifuddin M, et al. Among authors: hannan ma. Indian J Endocrinol Metab. 2024 Sep-Oct;28(5):500-509. doi: 10.4103/ijem.ijem_189_23. Epub 2024 Mar 8. Indian J Endocrinol Metab. 2024. PMID: 39676786 Free PMC article.
Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh.
Pathan MDF, Akter N, Selim S, Saifuddin M, Qureshi NK, Kamrul-Hasan ABM, Hannan MA, Ahmed MAU, Mustari M, Chakraborty AK. Pathan MDF, et al. Among authors: hannan ma. Diabetes Metab Syndr Obes. 2022 Dec 22;15:4011-4021. doi: 10.2147/DMSO.S380544. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 36578878 Free PMC article.
Comparison of simplicity, convenience, safety, and cost-effectiveness between use of insulin pen devices and disposable plastic syringes by patients with type 2 diabetes mellitus: a cross-sectional study from Bangladesh.
Kamrul-Hasan ABM, Hannan MA, Alam MS, Rahman MM, Asaduzzaman M, Mustari M, Paul AK, Kabir ML, Chowdhury SR, Talukder SK, Sarkar S, Hannan MA, Islam MR, Iftekhar MH, Robel MAB, Selim S. Kamrul-Hasan ABM, et al. Among authors: hannan ma. BMC Endocr Disord. 2023 Feb 13;23(1):37. doi: 10.1186/s12902-023-01292-8. BMC Endocr Disord. 2023. PMID: 36782190 Free PMC article.
Comparison of fasting and random lipid profiles among subjects with type 2 diabetes mellitus: an outpatient-based cross-sectional study in Bangladesh.
Kamrul-Hasan ABM, Talukder SK, Kabir MA, Mustari M, Un Nabi MM, Gaffar AJ, Hossain MF, Alam MS, Islam MR, Hannan MA, Zarin N, Paul AK, Akter F, Ahammed A, Kabir ML, Rahman MM, Asaduzzaman M, Saifuddin M, Chanda PK, Rafi MA, Hasan MJ, Selim S. Kamrul-Hasan ABM, et al. Among authors: hannan ma. Diabetol Metab Syndr. 2023 Jun 26;15(1):139. doi: 10.1186/s13098-023-01120-y. Diabetol Metab Syndr. 2023. PMID: 37365577 Free PMC article.
Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
Selim S, Alam MS, Talukder SK, Kabir ML, Gaffar AJ, Kabir MA, Zarin N, Rahman S, Nabi MMU, Mustari M, Hossain MF, Raunak AIB, Hoque MA, Islam MR, Akter F, Hannan MA, Saifuddin M, Asaduzzaman M, Rahman MM, Ahammed A, Rafi MA, Hasan MJ, Kamrul-Hasan ABM. Selim S, et al. Among authors: hannan ma. BMC Endocr Disord. 2023 Dec 5;23(1):268. doi: 10.1186/s12902-023-01522-z. BMC Endocr Disord. 2023. PMID: 38053073 Free PMC article.
237 results